Physician profile
Jonson J Lin
NPI 1114101995
$2,952.92
in general payments reported to CMS, 2019-2025
16 companies · $976 in 2025
The $976 reported for 2025 was more than what 81% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $121 · 2021: $234 · 2022: $876 · 2023: $492 · 2024: $254 · 2025: $976.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,721.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $609.86 | 2022-2025 | |
| Alkermes, INC. | $427.91 | 2022-2025 | Aristada, Lybalvi, Aristada Initio |
| Janssen Pharmaceuticals, INC | $390.96 | 2021-2024 | Spravato, Invega Sustenna |
| Teva Pharmaceuticals USA, INC. | $307.20 | 2022-2025 | Uzedy, Austedo Xr, Austedo |
| Neurocrine Biosciences, INC. | $244.44 | 2022-2025 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $214.98 | 2023-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $202.13 | 2021-2025 | Rexulti |
| Sunovion Pharmaceuticals INC. | $141.50 | 2020-2021 | |
| Vanda Pharmaceuticals INC. | $110.94 | 2021-2025 | Fanapt |
| E.R. Squibb & Sons, L.L.C. | $97.36 | 2025 | Cobenfy |
| Bausch Health US, LLC | $66.73 | 2025 | Aplenzin |
| Lundbeck LLC | $60.77 | 2025 | Rexulti |
| Supernus Pharmaceuticals, INC. | $24.37 | 2025 | |
| Indivior INC. | $21.03 | 2022 | |
| Axsome Therapeutics, INC. | $17.71 | 2024 | Auvelity |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $15.03 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonson Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.